Literature DB >> 1924655

Plasma catecholamines during behavioral treatments for Raynaud's disease.

R R Freedman1, D Keegan, P Migály, M P Galloway, M Mayes.   

Abstract

We have previously demonstrated that the vasospastic attacks of Raynaud's disease can be induced despite blockade of efferent digital nerves and that feedback-induced vasodilation is mediated through a non-neural, beta-adrenergic mechanism. Here, we sought to determine the role of sympathetic activity, as measured by plasma epinephrine and norepinephrine, during finger temperature feedback and autogenic training. Thirty-one female patients with idiopathic Raynaud's disease were randomly assigned to receive finger temperature feedback or autogenic training over 28 days. Half of each group began and finished training during the follicular phase of the menstrual cycle, the other half during the luteal phase. During training, significant temperature elevations were shown by feedback patients but not by autogenic patients. There were no significant effects for norepinephrine and epinephrine for either group. Cycle phase did not interact with training effects or with catecholamines. These findings do not support the role of decreased sympathetic activation in behavioral treatments for Raynaud's disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1924655     DOI: 10.1097/00006842-199107000-00008

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  2 in total

1.  Plasma catecholamine levels during temperature biofeedback training in normal subjects.

Authors:  R R Freedman; D Keegan; J Rodriguez; M P Galloway
Journal:  Biofeedback Self Regul       Date:  1993-06

2.  Raynaud phenomenon and mortality: 20+ years of follow-up of the Charleston Heart Study cohort.

Authors:  Paul J Nietert; Stephanie R Shaftman; Richard M Silver; Bethany J Wolf; Brent M Egan; Kelly J Hunt; Edwin A Smith
Journal:  Clin Epidemiol       Date:  2015-02-03       Impact factor: 4.790

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.